French hospital pilots early discharge for new moms with home midwife support
NCT ID NCT05438004
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new care plan for 100 low-risk mothers and their newborns, allowing them to go home within 24 hours after a normal vaginal delivery. Participants received daily visits from a midwife for the first three days and used a special mobile app to stay in touch with the hospital. The goal was to see if this early discharge plan could meet safety recommendations while giving women more choice in their postpartum care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Dec 2021
- Finished
-
Mar 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Maternal: * Voluntary * Legal age * Vaginal delivery * General Health Insurance Plan * Accompanying person present at discharge and every day during the first 2 days * Pain VAS \< 5 with or without simple analgesics * Mother-child interaction judged satisfactory by the team * Signature of consent * Pediatric : * Singleton * \> 38 weeks of amenorrhea * Eutrophic * Apgar \> 7 at 5 minutes of life * Respiratory rate \< 60/min; 90bpm \< Heart rate \< 170bpm; SaO2 \>95 * Axillary temperature between 36 and 37°C * Feeding established * Vitamin K1 given * Neonatal screenings organized Exclusion Criteria: * Maternal: * Social isolation, psychiatric disorder with impact on infant care, moderate to severe (according to DSM5) substance use disorder * Poorly balanced chronic condition requiring hospitalization * Postpartum complications requiring hospitalization * Postpartum hemorrhage \> 500mL * Body temperature \> 38.0°C without paracetamol * Thromboembolic signs: pain, edema, positive Homans sign * Protected persons defined in the following articles of the public health code: L. 1121-6: persons deprived of liberty by a judicial or administrative decision, persons hospitalized without consent and persons admitted to a health or social institution for purposes other than research; L. 1121-8: adults subject to a legal protection measure or unable to express their consent; L. 1122-1-2: persons in emergency situations unable to give prior consent. * Pediatric : * Jaundice * Risk factor for neonatal infection (maternal streptococcal B colonization during the current pregnancy, history of neonatal streptococcal B infection in a previous pregnancy, duration of rupture of membranes \> 12 hours, maternal temperature \> 38.0°C intrapartum or during the 2 hours following delivery).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pregnancy related are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Archet
Nice, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Mom's workout shape Baby's heart health?
- Can a TB infection leave a mark on the placenta?
- Can a newer hepatitis b drug protect babies while being gentler on their bones?
- Can virtual mindfulness groups support pregnant individuals at risk?
- Can surveillance catch birth defects early in HIV-Affected pregnancies?
- Could a smartphone program ease pregnancy stress?